Myeloid Leukemias Active Not Recruiting Phase 2 / 3 Trials for Cladribine (DB00242)

Also known as: Leukemia, Myeloid / Myeloid leukaemia / Myeloid Leukemia / Leukemia myeloid / Non-lymphoblastic leukaemia NOS / Leukemic granulocytic / Non-lymphoblastic leukemia NOS / Unspecified myeloid leukaemia / Unspecified myeloid leukemia / Leukaemia myelogenous / Leukemia myelogenous / Myelocytic leukaemia / Myelocytic leukemia / Leukemia granulocytic NOS / Leukaemia granulocytic NOS / Leukaemia granulocytic / Leukemia granulocytic / Leukaemia myeloid / Myeloid leukemia NOS / Myeloid leukaemia NOS

IndicationStatusPhase
DBCOND0042450 (Myeloid Leukemias)Active Not Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00111345Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and AdolescentsTreatment